Prestige Consumer Healthcare Inc. (PBH)

USD 84.19

(2.38%)

EBITDA Summary of Prestige Consumer Healthcare Inc.

  • Prestige Consumer Healthcare Inc.'s latest annual EBITDA in 2024 was 373.1 Million USD , up 2535.6% from previous year.
  • Prestige Consumer Healthcare Inc.'s latest quarterly EBITDA in 2024 FY was N/A , down -1.32% from previous quarter.
  • Prestige Consumer Healthcare Inc. reported an annual EBITDA of 14.18 Million USD in 2023, up 4.75% from previous year.
  • Prestige Consumer Healthcare Inc. reported an annual EBITDA of 351.61 Million USD in 2022, up 9.74% from previous year.
  • Prestige Consumer Healthcare Inc. reported a quarterly EBITDA of 89.99 Million USD for 2024 Q4, down -4.05% from previous quarter.
  • Prestige Consumer Healthcare Inc. reported a quarterly EBITDA of N/A for 2024 FY, down -1.32% from previous quarter.

Annual EBITDA Chart of Prestige Consumer Healthcare Inc. (2024 - 2001)

Historical Annual EBITDA of Prestige Consumer Healthcare Inc. (2024 - 2001)

Year EBITDA EBITDA Growth
2024 373.1 Million USD 2535.6%
2023 14.18 Million USD 4.75%
2022 351.61 Million USD 9.74%
2021 310.38 Million USD 3.16%
2020 325.49 Million USD -2.55%
2019 327.45 Million USD 31.05%
2018 355.72 Million USD -11.91%
2017 304.45 Million USD -0.26%
2016 266.18 Million USD 26.07%
2015 226.52 Million USD 11.49%
2014 183.87 Million USD -1.45%
2013 203.68 Million USD 80.61%
2012 113.22 Million USD 31.68%
2011 85.95 Million USD -9.04%
2010 84.63 Million USD 1.5%
2009 -156.16 Million USD -11.23%
2008 105.43 Million USD -2.84%
2007 94.68 Million USD 1.57%
2006 83.9 Million USD -19.92%
2005 103.1 Million USD 499.03%
2004 22.23 Million USD -31.89%
2003 32.64 Million USD 72.33%
2002 18.94 Million USD 288.87%
2001 4.87 Million USD 0.0%

Peer EBITDA Comparison of Prestige Consumer Healthcare Inc.

Name EBITDA EBITDA Difference
Cardinal Health, Inc. 1.97 Billion USD 81.137%
Cencora 3.25 Billion USD 88.53%
McKesson Corporation 4.66 Billion USD 92.005%
Owens & Minor, Inc. 400.28 Million USD 6.791%